The Problem: We Don’t Really Know! The problem with estimating the total cost burden of the autoimmune disease (AIID) epidemic is that we really don’t know! A May 2022 NIH report validates our long-held belief that missing and inconsistent data for autoimmune diseases (AIIDs) are at the root of the
Will long-COVID activists, especially practitioner-patients, finally force healthcare systems, clinicians and medical researchers to confront post-viral and similar chronic syndromes they have shrugged off for decades? In keeping with our mission, will a focused response by healthcare systems and researchers to post-COVID syndrome help illuminate the invisible epidemic of autoimmune and autoinflammatory disorders?
Dr Bonnie 360 interviews Chase Spurlock, PhD, founder and CEO of Decode Health on AI analytics in COVID and chronic inflammatory disease.
On GI practice, beta risk, digital health, VBP and chronic care Another in our new series of B2B thought leadership interviews with visionary entrepreneurs applying digital tools to improve care of chronic immunoinflammatory disorders (CID), including autoimmune and autoinflammatory diseases. We were delighted to speak with Dr Lawrence R. Kosinski,
Applying Technology to Empower Patients. 2016’s trends gave us glimmers of towards crossing the autoimmune abyss and achieving the vision of individualized autoimmune care. What was the state of autoimmunity in 2016, that unforgettable year full of positive and negative events? One positive development was increasing awareness of the unmet
The oral microbiome and its connection with autoimmune and other chronic diseases.
Spotlight on Myasthenia Gravis (MG) In this post, we deep dive into the symptoms, pathology, diagnosis, and treatment for MG.
Dr Bonnie360 explores how the oral microbiome interacts with the rest of the body, a possilbe mechanism for how gum disease may cause systemic diseases.